IP Library Granted Patent US 10,730,832
Granted Patent B2
US 10,730,832 · App. 16/312,259 · Granted Aug 4, 2020

Aliphatic prolinamide derivatives

Inventors: Austin Chih-Yu Chen (San Marcos, CA); Robert Gomez (North Vancouver, CA); Renata Marcella Oballa (Coquitlam, CA); David Andrew Powell (Vancouver, CA); Jeffrey Roger Roppe (Temecula, CA); Thomas Jon Seiders (San Diego, CA); Tao Sheng (Coquitlam, CA)
Assignee: ORION OPHTHALMOLOGY LLC
C07D207/16C07D401/04C07D401/14C07D403/04C07D403/14C07D405/14C07D409/14C07D413/14C07D471/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,730,832
App. No.
16/312,259
Granted
Aug 4, 2020
Kind
B2
Abstract

This invention is directed to novel aliphatic prolinamide derivatives of Formula I, and pharmaceutically acceptable salts, solvates, solvates of the salt and prodrugs thereof, useful in the prevention (e.g., delaying the onset of or reducing the risk of developing) and treatment (e.g., controlling, alleviating, or slowing the progression of) of age-related macular degeneration (AMD) and related diseases of the eye. These diseases include dry-AMD, wet-AMD, geographic atrophy, diabetic retinopathy, retinopathy of prematurity, polypoidal choroidal vasculopathy, and degeneration of retinal or photoreceptor cells. The invention disclosed herein is further directed to methods of prevention, slowing the progress of, and treatment of dry-AMD, wet-AMD, and geographic atrophy, diabetic retinopathy, retinopathy of prematurity, polypoidal choroidal vasculopathy, and degeneration of retinal or photoreceptor cells, comprising: administration of a therapeutically effective amount of compound of the invention. The compounds of the invention are inhibitors of HTRA1. Thus, the compounds of the invention are useful in the prevention and treatment of a wide range of diseases mediated (in whole or in part) by HTRA1. The compounds of the invention are also useful for inhibiting HTRA1 protease activity in an eye or locus of an arthritis or related condition.

Claims (525)

1. A compound of Formula (I):

or a pharmaceutically acceptable salt, solvate, solvate of the salt or prodrug thereof wherein:

R 1 is selected from the group consisting of:

(a) -aryl and

(b) -heteroaryl;

wherein the aryl and heteroaryl of choices (a) and (b) are each optionally substituted with 1 to 3 substituents independently selected from the group consisting of:

(i) -halogen,

(ii) —CN,

(iii) —C 1-6 alkyl,

(iv) —C 2-6 alkenyl,

(v) —C 2-6 alkynyl,

(vi) —C(O)R 8 ,

(vii) —CO 2 R 8 ,

(viii) —CONR 5 R 6 ,

(ix) —OH,

(x) —O—C 1-6 alkyl,

(xi) —SH,

(xii) —S(O) p —C 1-6 alkyl,

(xiii) —S(O) 2 NR 5 R 6 ,

(xiv) —NO 2 ,

(xv) —NR 5 R 6 ,

(xvi) —NHC(O)R 8 ,

(xvii) —NHC(O)OR 8 ,

(xviii) —NHC(O)NR 5 R 6 , and

(xix) —NHSO 2 C 1-6 alkyl,

wherein each of the alkyl group of choices (iii), (x), (xii) and (xix) is optionally substituted with 1 to 5 substituents independently selected from -halogen, -haloC 1-4 alkyl, —COR 8 , —CO 2 R 8 , —CONR 5 R 6 , —NR 5 R 6 , —OH, —O—C 1-4 alkyl, —SH and —S—C 1-4 alkyl;

R 2 is selected from the group consisting of:

(a) —C 3-8 alkyl,

(b) —C 0-6 alkyl-R 7 , and

(c) —(CH 2 ) 1-6 —N(R 13 )(R 13 ),

wherein each of the alkyl group of choices (a) and (b) is optionally substituted with 1 to 5 substituents independently selected from:

(i) -halogen,

(ii) —C 1-4 alkyl,

(iii) -haloC 1-4 alkyl,

(iv) —OH,

(v) —O—C 1-4 alkyl,

(vi) —SH, and

(vii) —S—C 1-4 alkyl;

R 3b and R 3c together represent —(CH 2 ) 2-3 —, and R 3a is H; or

R 3b and R 3c are each H, and R 3a is selected from the group consisting of:

wherein HAr is heteroaryl and Hcyl is heterocycle, wherein each of the aryl of choice (b), HAr and Hcyl is optionally substituted with 1 to 3 groups independently selected from the group consisting of:

(i) -halogen,

(ii) —OH,

(iii) —CR 10 R 11 R 12 ,

(iv) —(CH 2 ) 0-3 —NHSO 2 —C 1-4 alkyl, and

(v) —(CH 2 ) 0-3 —SO 2 —C 1-4 alkyl;

R 4 is selected from the group consisting of:

(a) —C 1-6 alkyl,

(b) -haloC 1-6 alkyl,

(c) —C 2-6 alkenyl,

(d) —C 2-6 alkynyl,

(e) —C 1-6 alkyl-C 3-6 cycloalkyl,

(f) —C 1-6 alkyl-aryl, wherein aryl is optionally substituted with nitro or —N(R 13 )(R 13 ),

(g) —C 1-6 alkyl-R 9 , and

(h) -haloC 1-6 alkyl-R 9 ;

each R 5 and each R 6 are independently selected from the group consisting of:

(a) —H,

(b) —C 1-6 alkyl,

(c) —C 0-6 alkyl-C 3-12 cycloalkyl,

(d) —C 0-6 alkyl-heterocyclyl,

(e) —C 0-6 alkyl-heteroaryl, and

(f) —C 0-6 alkyl-aryl,

wherein the alkyl group of choices (b)-(f) is optionally substituted with 1 to 3 groups independently selected from:

(i) -halogen,

(ii) —C(O)C 1-4 alkyl,

(iii) —C(O)OC 1-4 alkyl,

(iv) —OH,

(v) —OC 1-4 alkyl,

(vi) —SH,

(vii) —SC 1-4 alkyl,

(viii) —NH 2 ,

(ix) —NH(C 1-4 alkyl), and

(x) —N(C 1-4 alkyl)(C 1-4 alkyl); or

R 5 , R 6 and the nitrogen atom to which they are attached together form a 3- to 7-membered monocyclic or 6- to 11-membered bicyclic heterocycle optionally having an additional heteroatomic moiety selected from —O—, —S(O) p —, and —NR 13 —, and wherein said heterocycle is optionally substituted with 1 to 2 groups independently selected from halogen, -haloC 1-4 alkyl, —OH, —O—C 1-4 alkyl, —SH and —S—C 1-4 alkyl;

R 7 is selected from the group consisting of:

(a) —C 3-10 cycloalkyl, and

(b) —C 4-10 heterocyclyl,

wherein each of choices (a) and (b) is optionally substituted with 1 to 3 substituents independently selected from the group consisting of:

(i) —C 1-4 alkyl,

(ii) -halogen,

(iii) —OH,

(iv) —O—C 1-4 alkyl,

(v) —SH, and

(vi) —S—C 1-4 alkyl;

R 8 is selected from the group consisting of:

(a) —C 1-6 alkyl,

(b) —C 0-6 alkyl-C 3-12 cycloalkyl,

(c) —C 0-6 alkyl-heterocyclyl,

(d) —C 0-6 alkyl-heteroaryl, and

(e) —C 0-6 alkyl-aryl,

wherein each of the alkyl group of choices (a)-(e) is optionally substituted with 1 to 3 groups independently selected from:

(i) -halogen,

(ii) —OH,

(iii) —OC 1-4 alkyl,

(iv) —SH, and

(v) —SC 1-4 alkyl;

R 9 is selected from the group consisting of:

(a) —NH 2 ,

(b) —NH—C 1-4 alkyl,

(c) —N(C 1-4 alkyl) 2 ,

(d) —NH—C(═O)—NH 2 ,

(e) —NH—C(═O)—NH—C 1-4 alkyl,

(f) —NH—C(═O)—N(C 1-4 alkyl) 2 ,

(g) —NH—C(═O)—NH—C 3-5 alkenyl,

(h) —NH—C(═O)—NH—C 3-5 alkynyl,

(i) —NH—C(═O)—NH—C 3-6 cycloalkyl,

(j) —NH—C(═O)—NH-aryl,

(k) —NH—C(═O)—NH-heterocycle,

(l) —NH—C(═O)—NH-heteroaryl,

(m) —NH—C(═O)—NH—SO 2 —C 1-4 alkyl,

(n) —NH—C(═O)—NH—SO 2 —C 3-6 cycloalkyl,

(o) —NH—C(═O)—O—C 1-4 alkyl,

(p) —NH—C(═O)—O—C 1-4 alkylaryl,

(q) —NH—C(═O)—C 1-4 alkyl,

(r) —NH—C(═O)—C 3-6 cycloalkyl,

(s) —NH—C(═O)-aryl,

(t) —NH—C(═O)-heterocycle,

(u) —NH—C(═O)-heteroaryl, and

(v) —NH—SO 2 —C 1-4 alkyl,

wherein each of choices (b) to (v) is optionally substituted with 1 to 3 substituents independently selected from the group consisting of:

(i) —C 1-4 alkyl,

(ii) -halogen,

(iii) —OH,

(iv) —O—C 1-4 alkyl,

(v) —SH,

(vi) —S—C 1-4 alkyl;

(vii) —NO 2 , and

(viii) —CN;

R 10 , R 11 , and R 12 are independently selected from the group consisting of: H, halogen, —OH and —C 1-6 alkyl; or

R 10 , R 11 and the carbon atom to which they are attached together form a C 3-12 cycloalkyl or a heterocyclyl group;

R 13 is selected from the group consisting of:

(a) —H,

(b) —C 1-4 alkyl,

(c) —C(O)—C 1-4 alkyl,

(d) —C(O)NH 2 ,

(e) —C(O)—NH(C 1-4 alkyl),

(f) —C(O)—NH(C 3-6 cycloalkyl),

(g) —C(O)—N(C 1-4 alkyl) 2 ,

(h) —C(O)O—C 1-4 alkyl, and

(i) —C(O)O—C 1-4 alkylaryl;

p is 0, 1 or 2.

2. A compound of claim 1 wherein R 1 is selected from the group consisting of:

(a) -aryl and

(b) -heteroaryl;

wherein the aryl and heteroaryl of choices (a) and (b) are each optionally substituted with 1 to 3 substituents independently selected from the group consisting of:

(i) -halogen,

(ii) —CN,

(iii) —C(O)R 8 ,

(iv) —CONR 5 R 6 ,

(v) —OH,

(vi) —O—C 1-6 alkyl,

(vii) —S(O) p —C 1-6 alkyl,

(viii) —S(O) 2 NR 5 R 6 ,

(ix) —NHC(O)R 8 ,

(x) —NHC(O)OR 8 ,

(xi) —NHSO 2 C 1-6 alkyl,

wherein each of the alkyl group of choices (iii), (x), (xii) and (xix) is optionally substituted with 1 to 5 substituents independently selected from -halogen, -haloC 1-4 alkyl, —COR 8 , —CO 2 R 8 , —CONR 5 R 6 , —NR 5 R 6 , —OH, —O—C 1-4 alkyl, —SH and —S—C 1-4 alkyl.

3. A compound of claim 1 wherein R 2 is selected from the group consisting of:

(a) —C 1-6 alkyl-R 7 , and

(b) —(CH 2 ) 1-6 —N(R 13 )(R 13 ),

wherein the alkyl group of choice (a) is optionally substituted with 1 to 5 substituents independently selected from:

(i) -halogen,

(ii) —C 1-4 alkyl,

(iii) -haloC 1-4 alkyl,

(iv) —OH,

(v) —O—C 1-4 alkyl,

(vi) —SH, and

(vii) —S—C 1-4 alkyl.

4. A compound of claim 1 wherein R 2 is selected from the group consisting of:

(a) —(CH 2 ) 1-6 —R 7 , and

(b) —(CH 2 ) 1-6 —N(R 13 )(R 13 ).

5. A compound of claim 1 wherein R 3b and R 3c are each H, and R 3a is selected from the group consisting of:

wherein HAr is heteroaryl and Hcyl is heterocycle, wherein each of HAr and Hcyl is optionally substituted with 1 to 3 groups independently selected from the group consisting of:

(i) -halogen,

(ii) —OH,

(iii) —CR 10 R 11 R 12 ,

(iv) —(CH 2 ) 0-3 —NHSO 2 —C 1-4 alkyl, and

(v) —(CH 2 ) 0-3 —SO 2 —C 1-4 alkyl.

6. A compound of claim 1 wherein R 4 is selected from the group consisting of:

(a) —C 1-6 alkyl,

(b) —C 2-6 alkenyl,

(c) —C 1-6 alkyl-C 3-6 cycloalkyl,

(d) —C 1-6 alkyl-aryl, wherein aryl is optionally substituted with nitro or —N(R 13 )(R 13 ), and

(e) —C 1-6 alkyl-R 9 .

7. A compound of claim 1 wherein R 4 is —C 1-6 alkyl-R 9 .

8. A compound of claim 1 having the Formula (Ia):

or a pharmaceutically acceptable salt, solvate, solvate of the salt or prodrug thereof; wherein

R 1 is selected from the group consisting of:

(a) -aryl and

(b) -heteroaryl;

wherein the aryl and heteroaryl of choices (a) and (b) are each optionally substituted with 1 to 3 substituents independently selected from the group consisting of:

(i) -halogen,

(ii) —CN,

(iii) —C 1-6 alkyl,

(iv) —C 2-6 alkenyl,

(v) —C 2-6 alkynyl,

(vi) —C(O)R 8 ,

(vii) —CO 2 R 8 ,

(viii) —CONR 5 R 6 ,

(ix) —OH,

(x) —O—C 1-6 alkyl,

(xi) —SH,

(xii) —S(O) p —C 1-6 alkyl,

(xiii) —S(O) 2 NR 5 R 6 ,

(xiv) —NO 2 ,

(xv) —NR 5 R 6 ,

(xvi) —NHC(O)R 8 ,

(xvii) —NHC(O)OR 8 ,

(xviii) —NHC(O)NR 5 R 6 , and

(xix) —NHSO 2 C 1-6 alkyl,

wherein each of the alkyl group of choices (iii), (x), (xii) and (xix) is optionally substituted with 1 to 5 substituents independently selected from -halogen, -haloC 1-4 alkyl, —COR 8 , —CO 2 R 8 , —CONR 5 R 6 , —NR 5 R 6 , —OH, —O—C 1-4 alkyl, —SH and —S—C 1-4 alkyl;

each R 5 and each R 6 are independently selected from the group consisting of:

(a) —H,

(b) —C 1-6 alkyl,

(c) —C 0-6 alkyl-C 3-12 cycloalkyl,

(d) —C 0-6 alkyl-heterocyclyl,

(e) —C 0-6 alkyl-heteroaryl, and

(f) —C 0-6 alkyl-aryl,

wherein each of the alkyl groups of choices (b)-(f) is optionally substituted with 1 to 3 groups independently selected from:

(i) -halogen,

(ii) —C(O)C 1-4 alkyl,

(iii) —C(O)OC 1-4 alkyl,

(iv) —OH,

(v) —OC 1-4 alkyl,

(vi) —SH,

(vii) —SC 1-4 alkyl,

(viii) —NH 2 ,

(ix) —NH(C 1-4 alkyl), and

(x) —N(C 1-4 alkyl)(C 1-4 alkyl); or

R 5 , R 6 and the nitrogen atom to which they are attached together form a 3- to 7-membered monocyclic or 6- to 11-membered bicyclic heterocycle optionally having an additional heteroatomic moiety selected from —O—, —S(O) p —, and —NR 13 —, and wherein said heterocycle is optionally substituted with 1 to 2 groups independently selected from halogen, -haloC 1-4 alkyl, —OH, —O—C 1-4 alkyl, —SH and —S—C 1-4 alkyl;

R 7 is selected from the group consisting of:

(a) —C 3-10 cycloalkyl, and

(b) -heterocyclyl,

wherein each of choices (a) and (b) is optionally substituted with 1 to 3 substituents independently selected from the group consisting of:

(i) —C 1-4 alkyl,

(ii) -halogen,

(iii) —OH,

(iv) —O—C 1-4 alkyl,

(v) —SH, and

(vi) —S—C 1-4 alkyl;

R 8 is selected from the group consisting of:

(a) —C 1-6 alkyl,

(b) —C 0-6 alkyl-C 3-12 cycloalkyl,

(c) —C 0-6 alkyl-heterocyclyl,

(d) —C 0-6 alkyl-heteroaryl, and

(e) —C 0-6 alkyl-aryl,

wherein the alkyl group of choices (a)-(e) is optionally substituted with 1 to 3 groups independently selected from:

(i) -halogen,

(ii) —OH,

(iii) —OC 1-4 alkyl,

(iv) —SH, and

(v) —SC 1-4 alkyl;

R 9 is selected from the group consisting of:

(a) —NH 2 ,

(b) —NH—C 1-4 alkyl,

(c) —N(C 1-4 alkyl) 2 ,

(d) —NH—C(═O)—NH 2 ,

(e) —NH—C(═O)—NH—C 1-4 alkyl,

(f) —NH—C(═O)—N(C 1-4 alkyl) 2 ,

(g) —NH—C(═O)—NH—C 3-5 alkenyl,

(h) —NH—C(═O)—NH—C 3-5 alkynyl,

(i) —NH—C(═O)—NH—C 3-6 cycloalkyl,

(j) —NH—C(═O)—NH-aryl,

(k) —NH—C(═O)—NH-heterocycle,

(l) —NH—C(═O)—NH-heteroaryl,

(m) —NH—C(═O)—NH—SO 2 —C 1-4 alkyl,

(n) —NH—C(═O)—NH—SO 2 —C 3-6 cycloalkyl,

(o) —NH—C(═O)—O—C 1-4 alkyl,

(p) —NH—C(═O)—O—C 1-4 alkylaryl,

(q) —NH—C(═O)—C 1-4 alkyl,

(r) —NH—C(═O)—C 3-6 cycloalkyl,

(s) —NH—C(═O)-aryl,

(t) —NH—C(═O)-heterocycle,

(u) —NH—C(═O)-heteroaryl, and

(v) —NH—SO 2 —C 1-4 alkyl,

wherein each of choices (b) to (v) is optionally substituted with 1 to 3 substituents independently selected from the group consisting of:

(i) —C 1-4 alkyl,

(ii) -halogen,

(iii) —OH,

(iv) —O—C 1-4 alkyl,

(v) —SH,

(vi) —S—C 1-4 alkyl;

(vii) —NO 2 , and

(viii) —CN;

R 10 , R 11 , and R 12 are independently selected from the group consisting of: H, halogen, —OH and —C 1-6 alkyl; or

R 10 , R 11 and the carbon atom to which they are attached together form a C 3-12 cycloalkyl or a heterocyclyl group;

R 13 is selected from the group consisting of:

(a) —H,

(b) —C 1-4 alkyl,

(c) —C(O)—C 1-4 alkyl,

(d) —C(O)NH 2 ,

(e) —C(O)—NH(C 1-4 alkyl),

(f) —C(O)—NH(C 3-6 cycloalkyl),

(g) —C(O)—N(C 1-4 alkyl) 2 ,

(h) —C(O)O—C 1-4 alkyl, and

(i) —C(O)O—C 1-4 alkylaryl; and

p is 0, 1 or 2.

9. A compound of claim 8 wherein R 1 is selected from the group consisting of:

(a) -aryl, and

(b) -heteroaryl;

wherein the aryl and heteroaryl of choices (a) and (b) are each optionally substituted with 1 to 3 substituents independently selected from the group consisting of:

(i) -halogen,

(ii) —CN,

(iii) —C(O)R 8 ,

(iv) —CONR 5 R 6 ,

(v) —OH,

(vi) —O—C 1-6 alkyl,

(vii) —S(O) p —C 1-6 alkyl,

(viii) —S(O) 2 NR 5 R 6 ,

(ix) —NHC(O)R 8 ,

(x) —NHC(O)OR 8 , and

(xi) —NHSO 2 C 1-6 alkyl,

wherein each of the alkyl group of choices (vi), (vii), and (xi) is optionally substituted with 1 to 5 substituents independently selected from -halogen, -haloC 1-4 alkyl, —COR 8 , —CO 2 R 8 , —CONR 5 R 6 , —NR 5 R 6 , —OH, —O—C 1-4 alkyl, —SH and —S—C 1-4 alkyl;

R 7 is —C 3-10 cycloalkyl;

R 9 is selected from the group consisting of:

(a) —NH—C(═O)—NH—C 1-4 alkyl,

(b) —NH—C(═O)—N(C 1-4 alkyl) 2 ,

(c) —NH—C(═O)—NH—C 3-5 alkenyl,

(d) —NH—C(═O)—NH—C 3-5 alkynyl,

(e) —NH—C(═O)—NH—C 3-6 cycloalkyl,

(f) —NH—C(═O)—NH-aryl,

(g) —NH—C(═O)—NH-heterocycle,

(h) —NH—C(═O)—NH-heteroaryl,

(i) —NH—C(═O)—NH—SO 2 —C 1-4 alkyl,

(j) —NH—C(═O)—NH—SO 2 —C 3-6 cycloalkyl,

(k) —NH—C(═O)—O—C 1-4 alkyl, and

(l) —NH—C(═O)—O—C 1-4 alkylaryl,

wherein each of choices (a) to (l) is optionally substituted with 1 to 3 substituents independently selected from the group consisting of:

(i) —C 1-4 alkyl,

(ii) -halogen,

(iii) —OH,

(iv) —O—C 1-4 alkyl,

(v) —SH, and

(vi) —S—C 1-4 alkyl;

R 10 and R 11 are each —C 1-4 alkyl, or

R 10 , R 11 and the carbon atom to which they are attached together form a C 3-6 cycloalkyl or a 4- to 6-membered heterocycle, and

R 12 is —OH.

10. A compound of claim 1 having the formula (Ib):

or a pharmaceutically acceptable salt, solvate, solvate of the salt or prodrug thereof, wherein R 1 is selected from the group consisting of:

(a) -aryl, and

(b) -heteroaryl;

wherein the aryl and heteroaryl of choices (a) and (b) are each optionally substituted with 1 to 3 substituents independently selected from the group consisting of:

(i) -halogen,

(ii) —CN,

(iii) —C(O)R 8 ,

(iv) —CONR 5 R 6 ,

(v) —OH,

(vi) —O—C 1-6 alkyl,

(vii) —S(O) p —C 1-6 alkyl,

(viii) —S(O) 2 NR 5 R 6 ,

(ix) —NHC(O)R 8 ,

(x) —NHC(O)OR 8 ,

(xi) —NHSO 2 C 1-6 alkyl, and

(xii) C 1-4 alkyl;

wherein each of the alkyl group of choices (vi), (vii), and (xi) is optionally substituted with 1 to 5 substituents independently selected from -halogen, -haloC 1-4 alkyl, —COR 8 , —CO 2 R 8 , —CONR 5 R 6 , —NR 5 R 6 , —OH, —O—C 1-4 alkyl, —SH and —S—C 1-4 alkyl;

R 9 is selected from the group consisting of:

(m) —NH—C(═O)—NH—C 1-4 alkyl,

(n) —NH—C(═O)—N(C 1-4 alkyl) 2 ,

(o) —NH—C(═O)—NH—C 3-5 alkenyl,

(p) —NH—C(═O)—NH—C 3-5 alkynyl,

(q) —NH—C(═O)—NH—C 3-6 cycloalkyl,

(r) —NH—C(═O)—NH-aryl,

(s) —NH—C(═O)—NH-heterocycle,

(t) —NH—C(═O)—NH-heteroaryl,

(u) —NH—C(═O)—NH—SO 2 —C 1-4 alkyl,

(v) —NH—C(═O)—NH—SO 2 —C 3-6 cycloalkyl,

(w) —NH—C(═O)—O—C 1-4 alkyl, and

(x) —NH—C(═O)—O—C 1-4 alkylaryl,

wherein each of choices (a) to (l) is optionally substituted with 1 to 3 substituents independently selected from the group consisting of:

(vii) —C 1-4 alkyl,

(viii) -halogen,

(ix) —OH,

(x) —O—C 1-4 alkyl,

(xi) —SH, and

(xii) —S—C 1-4 alkyl; and

n is 1 to 5.

11. A compound of claim 10 wherein n is 4.

12. A compound of claim 10 wherein R 1 is phenyl optionally substituted with 1 to 3 substituents independently selected from the group consisting of:

(i) -halogen,

(ii) —CN,

(iii) —C(O)R 8 ,

(iv) —CONR 5 R 6 ,

(v) —OH,

(vi) —O—C 1-6 alkyl,

(vii) —S(O) p —C 1-6 alkyl, and

(viii) —S(O) 2 NR 5 R 6 ;

wherein each of the alkyl group of choices (vi) and (vii) is optionally substituted with 1 to 5 substituents independently selected from -halogen, -haloC 1-4 alkyl, —COR 8 , —CO 2 R 8 , —CONH 2 , —OH, and —O—C 1-4 alkyl.

13. A compound of claim 10 wherein R 1 is naphthyl.

14. A compound of claim 10 wherein R 1 is selected from the group consisting of:

(a) 5- or 6-membered monocyclic heteroaryl ring having a heteroatom selected from N, O and S, and optionally 1, 2 or 3 additional N atoms; and

(b) 8-, 9-, or 10-membered fused bicyclic heteroaryl ring having a heteroatom selected from N, O and S, and optionally 1, 2 or 3 additional N atoms;

wherein each of choices (a) and (b) is optionally substituted with a group selected from: OH and C 1-4 alkyl.

15. A compound of claim 1 selected from the group consisting of:

(2S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-4-methyl-1,2-dioxopentan-3-yl)pyrrolidine-2-carboxamide;

methyl (3-((S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)pyrrolidine-2-carboxamido)-4-methyl-2-oxopentanoyl)glycinate;

(2S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-((2-methoxyethyl)amino)-4-methyl-1,2-dioxopentan-3-yl)pyrrolidine-2-carboxamide;

(2S,4R)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-4-methyl-1,2-dioxopentan-3-yl)-4-phenylpyrrolidine-2-carboxamide;

(2S,4R)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-4-methyl-1,2-dioxopentan-3-yl)-4-(piperidin-1-yl)pyrrolidine-2-carboxamide;

(2S,4R)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-7-(3-cyclohexylureido)-2-hydroxy-1-oxoheptan-3-yl)-4-(piperidin-1-yl)pyrrolidine-2-carboxamide;

(2S,4R)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-4-(piperidin-1-yl)pyrrolidine-2-carboxamide;

(2S,4R)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-4-methyl-1,2-dioxohexan-3-yl)-4-(piperidin-1-yl)pyrrolidine-2-carboxamide;

(2S,4R)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-4-(piperidin-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-4-(piperidin-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-7-(3-cyclopropylureido)-1,2-dioxoheptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-7-(3-isobutylureido)-1,2-dioxoheptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-7-(3-cyclohexylureido)-1,2-dioxoheptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-1,2-dioxo-7-(3-(pyridin-4-yl)ureido)heptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-7-(3-ethylureido)-1,2-dioxoheptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-7-(3-(1-methyl-1H-pyrazol-3-yl)ureido)-1,2-dioxoheptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-7-(3-(isoxazol-3-yl)ureido)-1,2-dioxoheptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-1,2-dioxo-7-(3-(tetrahydro-2H-pyran-4-yl)ureido)heptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-1,2-dioxo-7-(3-(pyrimidin-5-yl)ureido)heptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-7-(3-(1-oxidotetrahydro-2H-thiopyran-4-yl)ureido)-1,2-dioxoheptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-1,2-dioxo-7-(3-(tetrahydro-2H-thiopyran-4-yl)ureido)heptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-1,2-dioxo-7-(3-(pyridin-3-yl)ureido)heptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-1,2-dioxo-7-(3-(pyridin-2-yl)ureido)heptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-1,2-dioxo-7-(3-(prop-2-yn-1-yl)ureido)heptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-7-(3-(5-(tert-butyl)isoxazol-3-yl)ureido)-1,2-dioxoheptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(7-(3-allylureido)-1-amino-1,2-dioxoheptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-7-(3-(cyanomethyl)ureido)-1,2-dioxoheptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-7-(3-cyclobutylureido)-1,2-dioxoheptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-1,2-dioxo-7-((trifluoromethyl)sulfonamido)heptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-7-(3-(cyclopropyl sulfonyl)ureido)-1,2-dioxoheptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

benzyl (5-((2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-7-amino-6,7-dioxoheptyl)carbamate;

benzyl (5-((2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-4-(4-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-7-amino-6,7-dioxoheptyl)carbamate;

benzyl (5-((2S,4R)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-7-amino-6,7-dioxoheptyl)carbamate;

benzyl (5-((2S,4R)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-4-(4-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-7-amino-6,7-dioxoheptyl)carbamate;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-amino-1,2-dioxohex-5-en-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

N-((2R)-1-((2S,4S)-2-((7-(3-propargylureido)-1-amino-1,2-dioxoheptan-3-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)isonicotinamide;

(2S,4S)—N-(7-(3-propargylureido)-1-amino-1,2-dioxoheptan-3-yl)-1-((R)-3-cyclohexyl-2-(4-(methylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)—N-(1-amino-1,2-dioxo-7-(3-(prop-2-yn-1-yl)ureido)heptan-3-yl)-1-((R)-3-cyclohexyl-2-(4-(2,2,2-trifluoro-1,1-dihydroxyethyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

benzyl (5-((2S,4S)-1-((R)-2-(1H-benzo[d]imidazole-2-carboxamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-7-amino-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(4-(methylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (5-((2S,4S)-1-((R)-2-(1H-benzo[d]imidazole-4-carboxamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-7-amino-6,7-dioxoheptyl)carbamate;

benzyl (5-((2S,4S)-1-((R)-2-(1H-benzo[d]imidazole-6-carboxamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-7-amino-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1,6-naphthyridine-5-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1,6-naphthyridine-8-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1,8-naphthyridine-4-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(quinoxaline-5-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(quinazoline-2-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(quinoxaline-2-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1,5-naphthyridine-2-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1,6-naphthyridine-2-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1,8-naphthyridine-2-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1,7-naphthyridine-3-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1,5-naphthyridine-3-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(quinoxaline-6-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(4-oxo-3,4-dihydroquinazoline-7-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1,5-naphthyridine-4-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1-methyl-1H-imidazole-5-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1-methyl-1H-imidazole-4-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1-methyl-1H-imidazole-2-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1H-pyrrolo[3,2-c]pyridine-2-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1H-indole-2-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1H-indole-5-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1H-indole-6-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1H-indazole-4-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1H-indazole-5-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1H-indazole-6-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1H-indazole-7-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (5-((2S,4S)-1-((R)-2-(1-naphthamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-7-amino-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(isoxazole-4-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(oxazole-4-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(oxazole-2-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-2-(3-carbamoylbenzamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-2-(4-carbamoylbenzamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-2-(2-cyanobenzamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-2-(3-cyanobenzamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-2-(4-cyanobenzamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(2-fluorobenzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(4-fluorobenzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(2-methoxybenzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(3-methoxybenzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(4-methoxybenzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(2-((methylperoxy)thio)benzamido)-propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(3-((methylperoxy)thio)benzamido)-propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(4-((difluoromethyl)sulfonyl)benzamido)-propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(4-((2-methoxyethyl)sulfonyl)benzamido)-propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-2-(4-((2-amino-2-oxoethyl)sulfonyl)benzamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(4-(isopropylsulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(nicotinamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(picolinamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(isonicotinamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(pyrimidine-2-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(isoquinoline-1-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(quinoline-4-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(quinoline-5-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(isoquinoline-5-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(isoquinoline-8-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(quinoline-8-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(quinoline-2-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1-oxo-1,2-dihydroisoquinoline-3-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(isoquinoline-3-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(quinoline-3-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(2-oxo-1,2-dihydroquinoline-6-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(isoquinoline-6-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(isoquinoline-7-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(imidazo[1,2-a]pyridine-6-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(quinoline-7-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(pyrido[2,3-b]pyrazine-8-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(pyrido[2,3-b]pyrazine-6-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(pyrido[2,3-b]pyrazine-7-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1H-1,2,3-triazole-4-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (7-amino-5-((2S,4S)-1-((R)-3-cyclohexyl-2-(1-methyl-1H-1,2,3-triazole-4-carboxamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-6,7-dioxoheptyl)carbamate;

(2S,4S)—N-(1-amino-7-(3-cyclopropylureido)-1,2-dioxoheptan-3-yl)-1-((R)-3-cyclohexyl-2-(4-(methyl sulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)—N-(1-amino-7-(3-cyclopropylureido)-1,2-dioxoheptan-3-yl)-1-((R)-2-(4-cyanobenzamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

N-((2R)-1-((2S,4S)-2-((1-amino-7-(3-cyclopropylureido)-1,2-dioxoheptan-3-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)imidazo[1,2-a]pyridine-6-carboxamide;

N-((2R)-1-((2S,4S)-2-((1-amino-7-(3-cyclopropylureido)-1,2-dioxoheptan-3-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)quinoline-3-carboxamide;

(2S,4S)-1-((R)-2-(4-((2-amino-2-oxoethyl)sulfonyl)benzamido)-3-cyclohexylpropanoyl)-N-(1-amino-7-(3-cyclopropylureido)-1,2-dioxoheptan-3-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)—N-(1-amino-7-(3-cyclopropylureido)-1,2-dioxoheptan-3-yl)-1-((R)-3-cyclohexyl-2-(4-((difluoromethyl)sulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

N-((2R)-1-((2S,4S)-2-((1-amino-7-(3-cyclopropylureido)-1,2-dioxoheptan-3-yl)carbamoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidin-1-yl)-3-cyclohexyl-1-oxopropan-2-yl)-1H-indazole-7-carboxamide;

(2S,4S)—N-(1-amino-7-(3-cyclopropylureido)-1,2-dioxoheptan-3-yl)-1-((R)-3-cyclohexyl-2-(4-((2-methoxyethyl)sulfonyl)benzamido)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(4-amino-1-(4-nitrophenyl)-3,4-dioxobutan-2-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(1-(4-acetamidophenyl)-4-amino-3,4-dioxobutan-2-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

(2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-N-(4-amino-1-(4-(3-cyclohexylureido)phenyl)-3,4-dioxobutan-2-yl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamide;

benzyl (2-((2S,4S)-1-((R)-2-(2-naphthamido)-3-cyclohexylpropanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-4-amino-3,4-dioxobutyl)carbamate;

benzyl (7-amino-5-((3S)-2-((R)-3-cyclohexyl-2-(4-(methylsulfonyl)benzamido)propanoyl)-2-azabicyclo[2.2.1]heptane-3-carboxamido)-6,7-dioxoheptyl)carbamate;

benzyl (5-((2S,4S)-1-(2-(2-naphthamido)-4-((1S,4R)-bicyclo[2.2.1]heptan-2-yl)butanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-7-amino-6,7-dioxoheptyl)carbamate;

benzyl (5-((2S,4S)-1-((R)-2-(2-naphthamido)-3-(((benzyloxy)carbonyl)amino)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-7-amino-6,7-dioxoheptyl)carbamate;

benzyl (5-((2S,4S)-1-(2-(2-naphthamido)-3-(tetrahydro-2H-pyran-4-yl)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-7-amino-6,7-dioxoheptyl)carbamate;

benzyl (5-((2S,4S)-1-(2-(2-naphthamido)-3-((3S,5S,7S)-adamantan-1-yl)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-7-amino-6,7-dioxoheptyl)carbamate;

benzyl (5-((2S,4S)-1-(2-(2-naphthamido)-3-((1S,2R,5S)-6,6-dimethylbicyclo[3.1.1]heptan-2-yl)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-7-amino-6,7-dioxoheptyl)carbamate; and

benzyl (5-((2S,4S)-1-(2-(2-naphthamido)-3-(3-methyloxetan-3-yl)propanoyl)-4-(5-(2-hydroxypropan-2-yl)-1H-1,2,3-triazol-1-yl)pyrrolidine-2-carboxamido)-7-amino-6,7-dioxoheptyl)carbamate;

or a pharmaceutically acceptable salt, solvate, salt of the solvate or prodrug thereof.

16. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jul 17, 2023
From: HERCULES CAPITAL, INC.
To: IVERIC BIO, INC.; IVERIC BIO GENE THERAPY LLC; ORION OPHTHALMOLOGY LLC
Reel/Frame 064286/0472 →
SECURITY INTEREST Recorded Aug 5, 2022
From: IVERIC BIO, INC.
To: HERCULES CAPITAL, INC.
Reel/Frame 061088/0048 →
MERGER Recorded Oct 25, 2019
From: INCEPTION 4, INC.
To: ORION OPHTHALMOLOGY LLC
Reel/Frame 050832/0891 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2019
From: INCEPTION SCIENCES, INC.
To: INCEPTION 4, INC.
Reel/Frame 050691/0387 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2019
From: CHEN, AUSTIN CHIH-YU; GOMEZ, ROBERT; OBALLA, RENATA MARCELLA; POWELL, DAVID ANDREW; ROPPE, JEFFREY ROGER; SEIDERS, THOMAS JON; SHENG, TAO
To: INCEPTION SCIENCES, INC.
Reel/Frame 050429/0880 →
Continuity (2)
Provisional Application 62352965 · Jun 21, 2016
Related Publication 20190330146A1 · Oct 31, 2019